Twin Vee PowerCats, Co.
VEEE Nasdaq Ship & Boat Building & Repairing Financials FY2020βFY2025
What Twin Vee PowerCats, Co. does
No business description yet.
- Legal name
- Twin Vee PowerCats, Co.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001731122-26-000317
0001855509
Revenue and margins
Twin Vee PowerCats, Co. had $14.8M of revenue in fiscal 2025, up 3.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$9.0M in fiscal 2025, β61.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Twin Vee PowerCats, Co. returned β to shareholders in fiscal 2025. The diluted share count rose 96.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Twin Vee PowerCats, Co. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $10.0M | $25.0M | $21.0M | $7.5M | $1.4M |
| Debt incl. finance leases | $0.5M | $0.5M | $3.4M | $3.1M | $0.5M |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 6.1x | 7.9x | 6.3x | 2.8x | 2.2x |
| Quick ratio | 5.2x | 6.8x | 5.2x | 2.1x | 1.1x |
| Total assets | $20.6M | $38.2M | $39.8M | $25.9M | $16.2M |
| Total liabilities | $3.9M | $5.2M | $7.8M | $6.7M | $2.8M |
| Shareholders' equity | $16.7M | $28.4M | $23.5M | $19.2M | $13.5M |
| Net debt (β = net cash) | β$9.5M | β$24.5M | β$17.6M | β$4.3M | β$0.9M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 1 / 8 | 4 / 9 | 3 / 9 | 2 / 9 | 3 / 9 |
| Accruals ratio | 17.9% | 7.5% | β3.4% | β0.7% | β12.4% | β8.2% |
| Altman Z'' | 1.47 | 7.12 | 8.54 | 3.66 | β2.26 | β4.28 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $11.1M | $15.8M | $32.0M | $33.4M | $14.4M | $14.8M |
| Net interest income | β$0.2M | β$0.1M | β$0.2M | β$0.2M | β$0.2M | β$0.1M |
| Gross profit | $4.8M | $6.3M | $10.7M | $3.3M | β$0.8M | $1.3M |
| Research and development | $0.0M | $0.2M | $0.9M | $1.4M | $0.6M | β |
| Operating income | $0.7M | β$1.6M | β$6.0M | β$12.0M | β$14.6M | β$8.8M |
| Income tax | $0.0M | $0.0M | β | β | β | β |
| Net income | $1.2M | β$1.0M | β$5.1M | β$7.2M | β$11.0M | β$8.6M |
| Net income to common | β | β$1.0M | β$5.1M | β | β | β |
| Diluted EPS | $0.29 | β$0.19 | β$0.67 | β$0.76 | β$11.01 | β$4.37 |
| Diluted shares | 0.00B | 0.01B | 0.01B | 0.01B | 0.00B | 0.00B |
| Cash flow | ||||||
| Cash from operations | $0.4M | β$1.9M | β$4.1M | β$6.9M | β$7.0M | β$6.9M |
| Capital expenditure | $0.5M | $1.9M | $3.4M | $5.2M | $6.3M | $2.2M |
| Free cash flow | β$0.2M | β$3.9M | β$7.5M | β$12.1M | β$13.3M | β$9.0M |
| Depreciation and amortization | $0.2M | $0.2M | $0.6M | $1.4M | $1.7M | $1.7M |
| Stock-based compensation | β | $0.3M | $1.4M | $1.9M | $1.2M | $0.3M |
| Balance sheet | ||||||
| Cash and short-term investments | $0.9M | $10.0M | $25.0M | $21.0M | $7.5M | $1.4M |
| Total debt | β | $0.5M | $0.5M | $0.5M | $0.5M | $0.5M |
| Finance lease liabilities | β | β | β | $2.9M | $2.6M | $0.0M |
| Current assets | $1.8M | $13.1M | $29.9M | $26.6M | $10.4M | $4.9M |
| Current liabilities | $1.4M | $2.2M | $3.8M | $4.2M | $3.7M | $2.2M |
| Inventory | $0.9M | $1.8M | $4.0M | $4.9M | $2.5M | $2.5M |
| Property and equipment, net | $1.4M | $2.9M | $5.5M | $12.3M | $15.0M | $8.3M |
| Total assets | $4.5M | $20.6M | $38.2M | $39.8M | $25.9M | $16.2M |
| Total liabilities | $3.0M | $3.9M | $5.2M | $7.8M | $6.7M | $2.8M |
| Preferred stock | β | β | β | $0.0M | β | β |
| Shareholders' equity | $1.5M | $16.7M | $28.4M | $23.5M | $19.2M | $13.5M |
| Margins | ||||||
| Gross margin | 43.2% | 39.8% | 33.3% | 9.8% | β5.2% | 8.5% |
| Operating margin | 6.5% | β10.3% | β18.8% | β35.9% | β101.1% | β59.3% |
| EBITDA margin | 7.9% | β9.1% | β17.1% | β31.8% | β89.0% | β47.6% |
| Net margin | 10.6% | β6.4% | β16.1% | β21.5% | β76.8% | β58.1% |
| FCF margin | β1.5% | β24.6% | β23.5% | β36.2% | β92.5% | β61.0% |
| Net interest share of revenue | β1.6% | β0.9% | β0.5% | β0.7% | β1.5% | β0.5% |
| Returns | ||||||
| Return on capital | β | β17.8% | β120.3% | β310.4% | β94.0% | β55.3% |
| Return on capital employed | 23.5% | β8.8% | β17.5% | β33.6% | β65.7% | β62.8% |
| Return on equity | 75.6% | β11.1% | β22.8% | β27.7% | β51.7% | β52.7% |
| Return on assets | 26.0% | β8.1% | β17.5% | β18.4% | β33.6% | β40.9% |
| Return on tangible equity | 75.6% | β6.1% | β18.1% | β30.6% | β57.5% | β63.9% |
| Growth | ||||||
| Revenue growth | β | 42.6% | 102.8% | 4.5% | β57.0% | 3.0% |
| Net income growth | β | β186.3% | β | β | β | β |
| EPS growth | β | β165.5% | β | β | β | β |
| Share count change | β | 33.3% | 43.0% | 24.9% | β89.5% | 96.2% |
| Financial health | ||||||
| Debt / equity | β | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 1.3x | 6.1x | 7.9x | 6.3x | 2.8x | 2.2x |
| Quick ratio | 0.6x | 5.2x | 6.8x | 5.2x | 2.1x | 1.1x |
| Capital allocation | ||||||
| Capex / revenue | 4.7% | 12.3% | 10.5% | 15.4% | 44.1% | 14.6% |
| Stock comp / revenue | β | 2.0% | 4.5% | 5.7% | 8.2% | 2.0% |
| Quality scores | ||||||
| Piotroski F-score | β | 1.0 | 4.0 | 3.0 | 2.0 | 3.0 |
| Altman Z'' | 1.5 | 7.1 | 8.5 | 3.7 | β2.3 | β4.3 |
| Accruals ratio | 17.9% | 7.5% | β3.4% | β0.7% | β12.4% | β8.2% |
Source: SEC EDGAR XBRL filings (CIK 0001855509). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.